Semper Paratus Acquisition Corp

Status: Deal Closed
U=S+W/2 W=S@11.50
IPO Proceeds, $M $345.00M
IPO Date Nov 4, 2021
CEO Surendra Ajjarapu
Left Lead Cantor Fitzgerald
IPO Cash in Trust 102.0%
SPAC Tenor 15 + 10 + 9
IPO Sector Industrial

Transportation, supply chain and logistics

IPO Geography Global
Target Company Tevogen Bio
Deal Announced Jun 29, 2023
Deal Size, $M $1,200.00M
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote Jan 29, 2024
Amendment Vote Dec 14, 2023
Closing Date Feb 14, 2024
Formerly LGST TVGN TVGNW

Sign up for Free Trial

No credit card required

Sign in for more on Semper Paratus Acquisition Corp:

  • Structure and cap table
  • 6 directors & officers
  • 29 filings and events
  • 1 underwriters
  • 1 deal advisors
  • 2 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Surendra Ajjarapu CEO & Chairman
Francis Knuettel II CFO
Michael Peterson Director
Donald Fell Director
Avinash Wadhwani Director
Scott Sussman Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Cantor Fitzgerald BR 30,000,000 units
30,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 4.26 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 29 filings.

Shareholders

Sign in to view shareholders 13F filing data.